Artemis DNA Forays Into Multi-Billion Dollar Cancer Liquid Biopsy Market

The $250 million contract gives Artemis DNA exclusivity to commercialize and distribute Trucheck Pragma and Cancertrack liquid biopsy tests in the USA and Vietnam. IRVINE, Calif. , May 16, 2022 /PRNewswire/ -- Artemis DNA, Inc. ("Artemis DNA" or the "company"), a leading USA-based...

Click to view original post